These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24588751)

  • 1. P2Y12 platelet function assay for assessment of bleeding risk in coronary artery bypass grafting.
    Yu PJ; Cassiere HA; Dellis SL; Manetta F; Stein J; Hartman AR
    J Card Surg; 2014 May; 29(3):312-6. PubMed ID: 24588751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study.
    Reed GW; Kumar A; Guo J; Aranki S; Shekar P; Agnihotri A; Maree AO; McLean DS; Rosenfield K; Cannon CP
    Clin Cardiol; 2015 Feb; 38(2):92-8. PubMed ID: 25655085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
    Firstenberg MS; Dyke CM; Angiolillo DJ; Ramaiahm C; Price M; Brtko M; Welsby I; Chandna H; Holmes DR; Voeltz M; Tummala P; Hutyra M; Manoukian SV; Prats J; Todd M; Liu T; Chronos N; Dietrich M; Montalescot G; Cannon LA; Topo EJ
    Heart Surg Forum; 2013 Apr; 16(2):E60-9. PubMed ID: 23625478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing of clopidogrel discontinuation in Japanese patients: platelet aggregation test using the VerifyNow® system.
    Takiuchi H; Tanemoto K
    Gen Thorac Cardiovasc Surg; 2015 Nov; 63(11):601-6. PubMed ID: 26298730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
    Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
    Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
    Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2Y12 platelet function assay as a key predictor for bleeding risk in coronary artery bypass grafting.
    Chen ZW; Tao H; Shi KH
    J Card Surg; 2014 Nov; 29(6):808. PubMed ID: 24943292
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting.
    Reichert MG; Robinson AH; Travis JA; Hammon JW; Kon ND; Kincaid EH
    Pharmacotherapy; 2008 Feb; 28(2):151-5. PubMed ID: 18225962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of point-of-care assessment of platelet function in predicting postoperative bleeding and transfusion requirements after coronary artery bypass grafting.
    Mishra PK; Thekkudan J; Sahajanandan R; Gravenor M; Lakshmanan S; Fayaz KM; Luckraz H
    Ann Card Anaesth; 2015; 18(1):45-51. PubMed ID: 25566711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery.
    Kang W; Theman TE; Reed JF; Stoltzfus J; Weger N
    J Surg Educ; 2007; 64(2):88-92. PubMed ID: 17462208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study.
    Mahla E; Suarez TA; Bliden KP; Rehak P; Metzler H; Sequeira AJ; Cho P; Sell J; Fan J; Antonino MJ; Tantry US; Gurbel PA
    Circ Cardiovasc Interv; 2012 Apr; 5(2):261-9. PubMed ID: 22396581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery.
    Maltais S; Perrault LP; Do QB
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):127-31. PubMed ID: 18455412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
    Mahla E; Tantry US; Prüller F; Gurbel PA
    Circulation; 2018 Nov; 138(19):2145-2159. PubMed ID: 30474416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery.
    Ranucci M; Colella D; Baryshnikova E; Di Dedda U;
    Br J Anaesth; 2014 Dec; 113(6):970-6. PubMed ID: 25209096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow assay? Role of haematocrit and haemoglobin levels.
    Voisin S; Bongard V; Tidjane MA; Lhermusier T; Carrié D; Sié P
    Thromb Haemost; 2011 Aug; 106(2):227-9. PubMed ID: 21544318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements.
    Filsoufi F; Rahmanian PB; Castillo JG; Kahn RA; Fischer G; Adams DH
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):60-6. PubMed ID: 18249332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function testing to time surgery in patients on dual antiplatelet therapy?
    Mahla E; Raggam R; Toller W
    Hamostaseologie; 2014; 34(1):40-5. PubMed ID: 24071994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
    Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
    Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
    Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.